Skip to content
Screener

Apyx Medical Corporation APYX Q3 2025 earnings

Reported November 6, 2025 · Before market open

Revenue$12.9MMiss by $5.2M
EPS-$0.05Beat by $0.01
Revenue estimate$18.1M
EPS estimate-$0.06

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$13.3M
EPS estimate-$0.07

Financials

Q3 2025

Income statement

See full
Revenue$12.9M+12.1%
Net income-$2.0M+58.6%

Balance sheet

See full
Cash & equivalents$25.1M-10.3%
Total debt$39.2M+0.9%
Total equity$5.8M-47.0%
Total assets$57.4M-5.5%

Cash flow

See full
Operating cash flow-$3.5M+20.4%
CapEx$519.0K+239%
Free cash flow-$4.1M+11.7%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$80.93M+88.4%
Enterprise value$95.01M+76.6%
P/S1.7×+0.8×

Profitability

See full
Net margin-30.3%-9.9pp
FCF margin-19.8%-6.3pp

Returns & leverage

See full
Return on equity-172%+89.1pp
Debt / equity6.7×+3.2×
Current ratio4.4×-1.0×

Segments

By segment

See full
Oem$1.8M-17.6%

FAQ

When did Apyx Medical Corporation report Q3 2025 earnings?
Apyx Medical Corporation (APYX) reported Q3 2025 earnings on November 6, 2025 before market open.
What were Apyx Medical Corporation's Q3 2025 revenue and EPS?
Apyx Medical Corporation reported revenue of $12.9M and eps of $-0.05 for Q3 2025.
Did Apyx Medical Corporation beat estimates in Q3 2025?
Revenue missed the consensus estimate of $18.1M by $5.2M. EPS beat the consensus estimate of $-0.06 by $0.01.
How did Apyx Medical Corporation's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 12.1% from $11.5M a year earlier and eps grew 64.3% from $-0.14.
Where can I find Apyx Medical Corporation's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001437749-25-033456) and the 10-Q periodic report (0001437749-25-033499) directly on SEC EDGAR. The filing index links above go to sec.gov.